FDA Adverse Event Injury Summary report: N

RADIESSE DERMAL FILLER

MDR report key: 1855808 · Received October 1, 2010

Report

Report Number
2135225-2010-00055
Event Type
Injury
Date Received
October 1, 2010
Date of Event
September 1, 2010
Report Date
September 27, 2010
Manufacturer
MERZ AESTHETICS, INC. (FORMERLY BIOFORM MEDICAL, INC.)
Product Code
LMH
PMA / PMN Number
P050052
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CO, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE HISTORY RECORDS FOR RADIESSE LOT 1016320 WERE REVIEWED; ALL REQUIRED TESTING SPECIFICATIONS WERE MET PRIOR TO RELEASE AND THERE WERE NO ABNORMALITIES NOTED FOR THIS LOT.

Description of Event or Problem · 1

PHYSICIAN REPORTED A PT WAS INJECTED WITH 0.8 CC RADIESSE INJECTABLE IMPLANT IN THE NASOLABIAL FOLDS AND GLABELLA, AND ABOUT 48 HOURS POST-INJECTION DEVELOPED INFLAMMATION MANIFESTED BY REDNESS, SWELLING AND BRUISING TO THE GLABELLA INJECTION SITE; A MICRO-EMBOLI TO THE GLABELLA WAS SUSPECTED AND THE PT WAS TREATED WITH ORAL DEXAMETHASONE. THE PT FURTHER DEVELOPED A MILD NECROSIS; EPIDERMOLYSIS AND BLISTERING TO THE LEFT GLABELLA ONLY. SHE HAD A MILD SLOUGH, WHICH HAS GONE ON TO FULL CLOSURE AND HEALED UP. SHE WAS LEFT WITH RESIDUAL ERYTHEMA THAT IS BEING TREATED WITH PULSED DYE LASER, AND SHE IS RECOVERING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 RADIESSE DERMAL FILLER RADIESSE INJECTABLE IMPLANT LMH MERZ AESTHETICS, INC. (FORMERLY BIOFORM MEDICAL, INC.) 1016320

Patients

Seq Age Sex Outcome Treatment
1 38 YR Required Intervention